Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

The company posted better-than-expected earnings for the last three months of 2019.

Why Shares of Chemours Are Up Today

Based on its high dividend and low forward P/E ratio, investors have clearly been discounting the likelihood of this chemical company's recovery.

Is This a Warning Signal or a Buy Sign for Chemours?

Lower volumes and prices in Titanium Technologies and Fluoroproducts units hurt Chemours' (CC) Q4 sales.

Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q4

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Implied Volatility Surging for Chemours (CC) Stock Options

Chemours Co. CC, +0.58% shares rose more than 6% Thursday after the chemicals company beat Wall Street expectations for its adjusted fourth-quarter profit.

Chemours stock rises after company beats adjusted profit views

Chemours's growth in many of its key industries is negative, yet the stock remains underpriced as per a number of key metrics.

Top 3 "Phoenix" Plays For Q1 2020: #3 The Chemours Co

AerCap Hlds

Assured Guaranty

Brighthouse Financial

DXC Technology

Greenlight Capital Re

General Motors

Green Brick Partners

Netflix

We begin 2020 with a portfolio that continues to be concentrated in our best ideas. We currently have 96% of capital in our top 10 longs and 47% of capital in our top 10 shorts.

Greenlight Capital Q4 2019 Letter

Chemours (CC) anticipates the collaboration to help Sharc Energy engage in refrigerant solutions that are more environmentally sustainable.

Chemours' Opteon XP10 Refrigerants Chosen by Sharc Energy

Regular readers of my articles will know that I follow the investment activities of David Einhorn (Trades, Portfolio) and his hedge fund Greenlight Capital closely.

A Look at David Einhorn's Most Undervalued Stock Holdings

Gap Inc

Meredith

Rio Tinto plc Sponsored

Investors are getting paid to wait for these high-yield dividend stocks to rise. The stocks have yields of 5% or higher and low P/E ratios.

5 Cheap, High-Yield Dividend Stocks for Investors in 2020

Duke Energy

Ford Motor Company

Kohl's

Macy's

Exxon Mobil

As we begin the new decade, take a look at these seven dividend stocks to consider grabbing for your portfolio.
The post 7 Dividend Stocks to Buy To Kick Off The New Year appeared first on InvestorPlace.

7 Dividend Stocks to Buy To Kick Off The New Year

I like to follow the investments of David Einhorn (Trades, Portfolio) because he has a reputation for being one of the best value investors of all time.

What Does David Einhorn Like About Chemours?

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

Chemours (CC) Down 22.2% Since Last Earnings Report: Can It Rebound?

Is the Options Market Predicting a Spike in Chemours (CC) Stock?

The titanium dioxide manufacturer performed well in the third quarter despite a challenging market environment.

Here's Why Chemours Rose as Much as 13.3% Today

The Chemours Company (CC) CEO Mark Vergnano on Q3 2019 Results - Earnings Call Transcript

Illegal imports of HFC refrigerants and weaker demand for base refrigerants hurt Chemours' (CC) Fluoroproducts unit in Q3.

Chemours (CC) Earnings Top, Revenues Miss Estimates in Q3

Chemours (CC) delivered earnings and revenue surprises of 5.36% and -0.19%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Chemours (CC) Beats Q3 Earnings Estimates

The top titanium dioxide manufacturer has seen its shares tumble. Is it now a bargain?

Is Chemours a Buy?

AEGON

Invesco

Triton International

These are five high-yield stocks with well-covered dividends and low P/E ratios. Investors get paid to wait for their prices to rise.

5 Excellent High-Yield Dividend Stocks to Buy

Chemours was spun-off of Dupont in 2015 and saddled with environmental and financial liabilities.

Chemours: A Cyclical, Industry-Leading Chemical Manufacturer Priced For A Severe Market Downturn

Weak TiO2 and Fluoroproducts demand is due to temporary macroeconomic headwinds, and not fundamental weakness.

The Chemours Conundrum: Fears Overblown Amidst Multiple Headwinds

The Chemours Company has to address severe headwinds this year, as 1H19 revenue, gross profit, and EPS tumbled.

The Chemours Company: Examining The Value

Chemours (CC) Down 22% Since Last Earnings Report: Can It Rebound?

Investors were anticipating weak second-quarter 2019 operating results. They were right.

News for Chemours Stock (CC)